A strong autoimmune response that involved the T cell recognition process was suggested as a reason for the increased risk of acute graft-versus-host disease in B*44 patients who required hematopoietic stem cell transplantation (HSCT) [24], implicating a significant role of activated CD8 positive T cells [25]. This evidence concerns the gene CD8A and acute graft versus host disease.